dobutamine hydrochloride 5% dextrose 2mg/ml (200mcg/ml) solution for injection iv
baxter healthcare phils inc - dobutamine hydrochloride 5% dextrose - solution for injection iv - 2mg/ml (200mcg/ml)
dobutamine hydrochloride continuous intravenous infusion 150mg syringe "kkc" (ドブタミン持続静注150mgシリンジ「kkc」)
kyowa kirin co.,ltd - dobutamine hydrochloride - injection
dobutamine hydrochloride continuous intravenous infusion 300mg syringe "kkc" (ドブタミン持続静注300mgシリンジ「kkc」)
kyowa kirin co.,ltd - dobutamine hydrochloride - injection
dobutamine hydrochloride continuous intravenous infusion 50mg syringe "kkc" (ドブタミン持続静注50mgシリンジ「kkc」)
kyowa kirin co.,ltd - dobutamine hydrochloride - injection
inotrop (dobutamine hcl 25mgml concentrate for solution for infusion)
medispec (m) sdn.bhd - dobutamine hydrochloride -
dobutamine pfizer 12.5 mg/ml concentrate for soln for inf
pfizer healthcare ireland - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml
dobutamine 12.5mg/ml concentrate for solution for infusion
baxter holding b.v. - dobutamine - concentrate for solution for infusion - 12.5 milligram(s)/millilitre - adrenergic and dopaminergic agents; dobutamine
dobutamine injection, solution
hikma farmaceutica - dobutamine hydrochloride (unii: 0wr771djxv) (dobutamine - unii:3s12j47372) -
dobutamine sandoz
sandoz pty ltd - dobutamine hydrochloride -
hospira dobutamine 12.5 mg/ml sterile concentrate 250 mg/20 ml vial
hospira australia pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - dobutamine is indicated for adults who require inotropic support in the treatment of low output cardiac failure associated with organic heart disease, myocardial infarction, open heart surgery, cardiomyophathies, septic shock and cardiogenic shock. dobutamine can increase or maintain cardiac output during positive end expiratory pressure ventilation.